While many often say the pharmaceutical industry has the most powerful lobby, the truth is many politicians have grown ...

Global trade uncertainty and evolving tariff policies are shifting how bioscience companies view their supply chains.   | ...

While the company is showing early signs of recovery and margin improvement, a high valuation means risks remain.

Throughout the visit, Goyal will address Indian diaspora groups and media representatives, aiming to convert policy momentum ...

Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...

Aquatech has acquired Singapore-based Century Water, a leader in ultrapure process water and wastewater recycling solutions ...

The private equity major picks up minority stake in Ireland's Felix Pharma, betting on fast-growing global market for generic ...

Korean pharmaceutical and biotechnology companies are gearing up for a strong presence at the 2025 BIO International ...

Drawing on his decades-long experience at the intersection of politics and economics, he now unpacks what the new phase of ...